Negative strand of hepatitis C virus RNA in the liver of patients with chronic hepatitis C after interferon treatment

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 9-10, 1997, Pages 629-632

  Tomimatsu, Masahiko ^a   Endou, Hitoshi ^a   Takahashi, Haruki ^a   Iga, Daijiro ^a   Kato, Yoshikazu ^a   Tamai, Norio ^a   Nakajima, Hiroko ^a   Okano, Akira ^a   Mori, Haruki ^a   Hisatomi, Hisashi ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SRL INC   (Japan)

Author keywords

Chronic hepatitis; HCV RNA; Hepatitis C virus; Interferon treatment; Negative strand; Positive strand

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; BETA INTERFERON; INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; LONG TERM CARE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 9844260507     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00525.x     Document Type: Article

References (15)

1. Chayama K, Saitoh S, Arase Y et al. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 1991; 13: 1040-3.
2. Bresci G, Parisi G, Banti S, Capzia A. Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha. J. Viral Hepat. 1995; 2: 155-8.
3. Balart LA, Perrillo R, Roddenberry J et al. Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment. Gastroenterology 1993; 104: 1472-7.
4. Shindo M, Arai K, Sokawa Y, Okuno T. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-α therapy. Ann. Intern. Med. 1995; 122: 586-91.
5. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
6. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990; 44: 649-88.
7. Gil B, Qlan C, Riezu-Boj JI, Civeira MP, Prieto J. Hepatic and extrahepatic HCV-RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology 1993; 18: 1050-4.
8. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
9. Chomczynski P, Sacchi N. Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156-9.
10. Shindo M, Okuno T, Matsumoto M et al. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B. Hepatology 1988; 8: 366-70.
11. Fong TL, Shindo M, Feinstone SM, Hoofnagle JH, Di Bisceglie AM. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J. Clin. Invest. 1991; 88: 1058-60.
12. Marcellin P, Boyer N, Giostra E et al. Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 1991; 13: 393-7.
13. Kasahara A, Hayashi N, Hiramatsu N et al. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 1995; 21: 291-7.
14. Hagiwara H, Hayashi N, Mita E et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993; 104: 877-83.
15. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543.